Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TER vs MRNA✓SelectedUSD · MRNATER vs MRNA performance historyLatest closeAs of+0.98%11/17
Stock and ETF performance explorer

TER vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+643.0%
MRNA return
+840.0%
Excess return
-197.0%
Maximum drawdown
-59.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.0%-3.9%+4.9%+1.3%
7D-4.6%-17.6%+13.0%-3.2%
30D-27.9%-5.1%-22.8%-27.7%
3M-47.1%+220.8%-268.0%-54.8%
6M-30.6%+321.7%-352.3%-43.7%
YTD+21.1%+601.3%-580.1%-9.7%
1Y+40.1%+735.2%-695.1%+1.6%
3Y+157.1%+170.5%-13.5%+109.5%
5Y+57.4%-14.6%+72.1%+38.7%
All+643.0%+840.0%-197.0%+488.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling